Author Topic: Neurontin ("gabapentin") Class Action  (Read 2278 times)

0 Members and 1 Guest are viewing this topic.


  • Administrator
  • Hero Member
  • **********
  • Posts: 1546
    • View Profile
    • Canadian Veterans Advocacy
Neurontin ("gabapentin") Class Action
« on: March 31, 2012, 04:07:50 PM »

Pharmaceutical and Medical Devices > Current Actions > Neurontin

      Neurontin ("gabapentin")
      In January 2005, Siskinds filed a class proceedings against Pfizer Canada Inc. and Pfizer Inc. with respect to Neurontin. Neurontin (generic name is "gabapentin") is a prescription anticonvulsant medication approved for use as a therapeutic antiepileptic agent, specifically as an adjunctive therapy for seizures. The vast majority of Neurontin sales are prescribed for "off label" use and ingestion of Neurontin has been linked to an increased risk of suicidal behaviour.
          o Amended Fresh as Amended Statement of Claim

      Siskinds is working with a national class counsel team to ensure the most effective representation possible for the class. The action is being managed by Justice Perell of the Ontario Superior Court of Justice.

      We are pleased to advise that on February 18, 2010, the action was certified as a class proceeding on a national basis, excluding Quebec. A copy of Justice Perell's decision is posted below:
          o Certification Decision
          o Press Release dated February 19, 2010

      The certification decision allows the claims of class members who used Neurontin and experienced suicidal behaviour to move forward as a class. The decision does not allow the claims of individuals who only used generic gabapentin to proceed.

      If you would like further information regarding this action please contact Joan Stewart at 519-672-2251 ext. 2382 or e-mail Joan by clicking on the Contact Us link below.
      Back to Siskinds Actions
Canadian Veterans Advocacy - One Veteran One Standard

Web Site:

Main FaceBook Group:

Main FaceBook Page: